@article{ce451188dbf447ac9e8f708632ff80c0,
title = "COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab",
keywords = "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy, Antibodies, Antineutrophil Cytoplasmic, COVID-19/prevention \& control, COVID-19 Vaccines, Humans, Immunologic Factors, Remission Induction, Rituximab/therapeutic use",
author = "Annette Bruchfeld and Andreas Kronbichler and Federico Alberici and Fervenza, \{Fernando C\} and Jayne, \{David R W\} and M{\aa}rten Segelmark and Vladimir Tesar and Szpirt, \{Wladimir M\}",
year = "2021",
month = aug,
day = "27",
doi = "10.1093/ndt/gfab174",
language = "English",
volume = "36",
pages = "1758--1760",
journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "9",
}